New England Research & Management, Inc. Abbott Laboratories Transaction History
New England Research & Management, Inc.
- $197 Million
- Q4 2024
A detailed history of New England Research & Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, New England Research & Management, Inc. holds 20,579 shares of ABT stock, worth $2.62 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
20,579
Previous 26,110
21.18%
Holding current value
$2.62 Million
Previous $2.98 Million
21.8%
% of portfolio
1.18%
Previous 1.4%
Shares
28 transactions
Others Institutions Holding ABT
# of Institutions
3,377Shares Held
1.33BCall Options Held
10.6MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$21.5 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$9.82 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.65 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$6.88 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $223B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...